These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Safe use of hydroxycarbamide in sickle cell disease patients hospitalized for painful vaso-occlusive episodes during the randomized, open-label HELPS study. Conran N; de Alvarenga Maximo C; Oliveira T; Fertrin KY; Lobo C; Costa FF Br J Haematol; 2022 Oct; 199(1):153-157. PubMed ID: 35834407 [No Abstract] [Full Text] [Related]
11. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease. Wang WC; Dwan K Cochrane Database Syst Rev; 2013 Nov; (11):CD003146. PubMed ID: 24226646 [TBL] [Abstract][Full Text] [Related]
12. Effect of hydroxyurea in sickle cell anemia: a clinical trial in children and teenagers with severe sickle cell anemia and sickle cell beta-thalassemia. Koren A; Segal-Kupershmit D; Zalman L; Levin C; Abu Hana M; Palmor H; Luder A; Attias D Pediatr Hematol Oncol; 1999; 16(3):221-32. PubMed ID: 10326220 [TBL] [Abstract][Full Text] [Related]
13. Hydroxyurea therapy: improving the lives of patients with sickle cell disease. Anderson N Pediatr Nurs; 2006; 32(6):541-3. PubMed ID: 17256291 [TBL] [Abstract][Full Text] [Related]
14. Hydroxyurea in children with sickle cell disease: impact on splenic function and compliance with therapy. Olivieri NF; Vichinsky EP J Pediatr Hematol Oncol; 1998; 20(1):26-31. PubMed ID: 9482409 [TBL] [Abstract][Full Text] [Related]
15. Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease. Estcourt LJ; Hopewell S; Trivella M; Hambleton IR; Cho G Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684693 [TBL] [Abstract][Full Text] [Related]
16. Magnesium for treating sickle cell disease. Than NN; Soe HHK; Palaniappan SK; Abas AB; De Franceschi L Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011358. PubMed ID: 31498421 [TBL] [Abstract][Full Text] [Related]
17. Magnesium for treating sickle cell disease. Than NN; Soe HHK; Palaniappan SK; Abas AB; De Franceschi L Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011358. PubMed ID: 28409830 [TBL] [Abstract][Full Text] [Related]
18. Sevuparin for the treatment of acute pain crisis in patients with sickle cell disease: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Biemond BJ; Tombak A; Kilinc Y; Al-Khabori M; Abboud M; Nafea M; Inati A; Wali Y; Kristensen J; Kowalski J; Donnelly E; Ohd J; Lancet Haematol; 2021 May; 8(5):e334-e343. PubMed ID: 33894169 [TBL] [Abstract][Full Text] [Related]
19. Role of hydroxycarbamide in prevention of complications in patients with sickle cell disease. Wiles N; Howard J Ther Clin Risk Manag; 2009; 5():745-55. PubMed ID: 19816573 [TBL] [Abstract][Full Text] [Related]